Aandeel Hikma Pharmaceuticals | Filter Basic-Info
Aandeel: Hikma Pharmaceuticals
| Koers | 2024.00 | Hoogste koers | 2338.00 |
| Laagste koers | 1794.00 | 1-jrs rend. | 27.90 |
| Sector | Gezondheid | Subsector | Farmaceuten |
Contactinformatie:Staat: 13 Hanover SquarePostcode: W1S 1HWStad: LondonLand: EngelandWebsite: http://www.hikma.com/
Sectorvergelijking Hikma Pharmaceuticals
| Jaar | Omzet | Totaal omzet sector | Marktaandeel |
|---|---|---|---|
| 2019 | 2,203 | 615,670 | 0.36 % |
| 2020 | 2,341 | 638,104 | 0.37 % |
| 2021 | 2,553 | 727,997 | 0.35 % |
| 2022 | 2,517 | 787,317 | 0.32 % |
| 2023 | 0 | 0 | 0.00 % |
Adviezen Hikma Pharmaceuticals
No Records Found
Nieuws Hikma Pharmaceuticals
No Records Found
Rapporten Hikma Pharmaceuticals
No Records Found
Profiel Hikma Pharmaceuticals
Hikma Pharmaceuticals
/ HIKl
Hikma Pharmaceuticals is vooral actief in de farmaciesector. De internationale farmaciesector won ruim 75 procent over de periode 2006-2016. Sinds 2011 staat de sector 147 procent hoger en over de voorbije 12 maanden (december 2015-december 2016) 75 procent verlies.
2016: relatief goed beleggingsjaar voor het aandeel Hikma Pharmaceuticals
Over het voorbije jaar verloor het aandeel circa 19 procent. Hikma Pharmaceuticals's beurskoers nam de afgelopen 5 jaar ruim 0 procent in waarde af.
De farmaceut keerde in de voorbije 5 jaar geen dividenden uit.
Het Engelse bedrijf had eind 2015 circa 0 miljoen aandelen uitstaan.
Op this page vindt u alle jaarverslagen van Hikma Pharmaceuticals. Meer omtrent Hikma Pharmaceuticals kunt u vinden op 's website. .
Resultaten Hikma Pharmaceuticals
| Resultaten |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Omzet |
1,440
|
1,950
|
1,936
|
2,076
|
2,203
|
2,341
|
| Kosten |
1,188
|
1,795
|
2,779
|
1,794
|
1,717
|
1,910
|
| Nettowinst |
252
|
155
|
-843
|
282
|
486
|
431
|
| Winstmarge |
17.50
|
7.95
|
-43.54
|
13.58
|
22.06
|
18.41
|
| ROI |
18.85
|
6.47
|
-55.68
|
16.74
|
22.96
|
20.19
|
Balans Hikma Pharmaceuticals
| Balans |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Eigen vermogen |
1,337
|
2,396
|
1,514
|
1,685
|
2,117
|
2,135
|
| Vreemd vermogen |
1,260
|
1,967
|
1,874
|
1,812
|
1,813
|
2,000
|
| Totaal vermogen |
2,597
|
4,363
|
3,388
|
3,497
|
3,930
|
4,135
|
| Solvabiliteit |
51.48
|
54.92
|
44.69
|
48.18
|
53.87
|
51.63
|
| Cash |
553
|
155
|
227
|
276
|
465
|
347
|
| Kasstroom |
366
|
293
|
443
|
430
|
472
|
464
|
| Werknemers |
0
|
0
|
0
|
0
|
0
|
|
| Omzet per werknemer |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
| Kasstroom / vreemd vermogen |
0.29
|
0.15
|
0.24
|
0.24
|
0.26
|
0.23
|
Details Hikma Pharmaceuticals
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Koers |
2301.00
|
1893.00
|
1134.00
|
1716.00
|
1991.00
|
| Winst per aandeel |
0.66
|
-3.51
|
1.17
|
2.00
|
1.81
|
| Koers / winst-verhouding |
3486.36
|
-539.32
|
969.23
|
858.00
|
1096.69
|
| Dividend |
0.33
|
0.34
|
0.38
|
0.47
|
0.51
|
| Dividend % |
0.01 %
|
0.02 %
|
0.03 %
|
0.03 %
|
0.03 %
|
| Payout % |
0.50
|
-0.10
|
0.32
|
0.23
|
0.28
|
| Boekwaarde |
9.94
|
6.29
|
6.98
|
8.74
|
9.26
|
| Boek / koers |
0.0
|
0.0
|
0.01
|
0.01
|
|
| Kasstroom per aandeel |
1.22
|
1.84
|
1.78
|
1.95
|
2.01
|
| Aandelen |
241
|
241
|
241
|
242
|
230
|
| Marktkap. |
554.541,00
|
455.605,14
|
273.809,97
|
415.819,40
|
457.459,13
|
Dividend Hikma Pharmaceuticals
Koersinfo Hikma Pharmaceuticals
|
Datum
|
Koers
|
|---|---|
|
09 mei
|
2024.00
|
|
01 mei
|
1985.00
|
|
29 apr
|
1937.00
|
|
22 apr
|
1885.00
|
|
09 apr
|
1794.00
|
|
08 apr
|
1794.00
|
|
03 apr
|
1937.00
|
|
30 maa
|
1963.00
|
|
27 maa
|
2010.00
|
|
26 maa
|
2006.00
|
|
20 maa
|
2022.00
|
|
15 maa
|
2012.00
|
|
12 maa
|
2104.00
|
|
01 maa
|
2160.00
|
|
25 feb
|
2304.00
|
|
23 feb
|
2310.00
|
|
18 feb
|
2318.00
|
|
13 feb
|
2338.00
|
|
12 feb
|
2338.00
|
|
07 feb
|
2284.00
|
|
05 feb
|
2272.00
|
|
02 feb
|
2292.00
|
|
21 jan
|
2084.00
|
|
17 jan
|
2072.00
|
|
09 jan
|
2062.00
|
|
17 dec
|
1938.00
|
|
10 dec
|
1958.00
|
|
06 dec
|
1940.00
|
|
03 dec
|
1934.00
|
|
29 nov
|
1935.00
|
